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Abstract
Background: Pulmonary embolism (PE) in children carries a significant morbidity and 
mortality. We examined previously described factors in 2 cohorts of children tested 
for PE and identified novel factors.
Methods: We combined data from 2 retrospective cohorts. Patients up to age 
21 years were included who underwent imaging or D‐dimer testing for PE, with posi‐
tive radiologic testing being the gold standard. Combined predictor variables were 
examined by univariate analysis and then forward stepwise multivariable logistic 
regression.
Results: The combined data set yielded 1103 patients with 42 unique predictor vari‐
ables, and 93 PE‐positive patients (8.4%), with a median age of 16 years. Univariate 
analysis retained 17 variables, and multivariable logistic regression found 9 signifi‐
cant variables with increased probability of PE diagnosis: age‐adjusted tachycardia, 
tachypnea, hypoxia, unilateral limb swelling, trauma/surgery requiring hospitalization 
in previous 4 weeks, prior thromboembolism, cancer, anemia, and leukocytosis.
Conclusion: This combined data set of children with suspected PE discovered factors 
that may contribute to a diagnosis of PE: hypoxia, unilateral limb swelling, trauma/
surgery requiring hospitalization in previous 4 weeks, prior thromboembolism, and 
cancer, age‐adjusted tachycardia, tachypnea, anemia, and leukocytosis. Prospective 
testing is needed to determine which criteria should be used to initiate diagnostic 
testing for PE in children.
Essentials
• Pulmonary embolism (PE) in children carries a significant morbidity and mortality.
• We combined data from 2 retrospective cohorts and identified novel predictor variables.
• Multivariable logistic regression found 9 significant variables associated with PE diagnosis.
• Prospective testing is needed to determine which features predict pediatric PE diagnosis.
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1  | INTRODUCTION
Pulmonary embolism (PE) occurs in only about 0.86 in 10 000 children 
in the general population each year but carries a high risk of mortal‐
ity (~10%).1‒12 When PE is considered in a differential diagnosis, there 
is considerable decisional conflict because the clinical presentation of 
PE overlaps with many common pediatric diseases. The current crite‐
rion standard for PE diagnosis is computed tomography pulmonary 
angiogram (CTPA), but this carries the risk of radiation‐induced malig‐
nancy.1,4,5,7,12‒14 Balancing the risk of missing a PE against the probable 
increased risk of a radiation‐induced malignancy presents a clinical 
conundrum for emergency medicine physicians caring for children. 
Contributing to this conundrum is the lack of quantitative data that 
have demonstrated which clinical factors increase the probability of PE 
diagnosis among children with clinically suspected PE.
Multiple decision rules exist for the pretest probability estima‐
tion of PE in adults, but these have had unreliable performance in 
children.6,13,15‒18 Prior studies extrapolating adult decision rules to 
children are limited by small numbers.1,4,13 The 8‐factor PE rule‐out 
criteria (PERC rule) for adult patients was derived and validated to 
rule out PE with no further testing. The PERC rule includes age < 50, 
heart rate < 100 beats/min, pulse oximetry reading > 94%, no estrogen 
use, no recent surgery, no prior venous thromboembolism (VTE), no 
hemoptysis, and no unilateral limb swelling.16,18,19 A single‐center ret‐
rospective study of children with PE had both higher mean heart and 
respiratory rates as well as lower pulse oximetry rates and hemoglobin 
concentrations, and they were more likely to have had recent surgery, 
an indwelling central line, limb immobility, prior PE or deep vein throm‐
bosis (DVT), and cancer on univariate analysis.5 However, this database 
had only 51 patients with PE, therefore limiting the selection of predic‐
tion variables based on univariate statistics (eg, t‐test or chi‐square).
When applied to 2 independent pediatric cohorts, the PERC 
rule had a high sensitivity for Hennelly et al4 (100%) and Kline et 
al13 (95.8%). However, specificities were lower, at 24% and 35%, 
respectively, which limits the usefulness of these rules in clinical 
practice. We recognize the possibility for improvement in exclu‐
sionary rate by adding or substituting pediatric‐focused clinical 
factors with the existing 8 criteria of PERC. Accordingly, the au‐
thors of this study collaborated to combine 2 separate data sets 
to create a larger database that contains predictor data and out‐
comes of children who underwent formal testing for PE. Using 
these combined data, we sought to report factors associated with 
a diagnosis of PE among pediatric patients presenting for evalua‐
tion, to design a future diagnostic algorithm.
2  | METHODS
We combined 2 previously reported data sets that evaluated chil‐
dren who underwent diagnostic testing for PE. Both studies were 
institutional review board approved by their institutions.
Hennelly et al4 performed a retrospective cohort study in 
Massachusetts of 561 children < 22 years of age who received 
diagnostic testing for the evaluation of PE in the emergency depart‐
ment (ED) or hospital setting between January 2000 and April 2014 
at Boston Children’s Hospital. Patients needed to have testing per‐
formed in the ED or within 7 days of hospitalization to be included. 
This was chosen a priori, as some children were admitted with an 
unclear or alternate diagnosis, but subsequent testing was done for 
PE. The study included patients undergoing ≥1 of the following di‐
agnostic tests specifically for the evaluation of suspected PE: CTPA 
(date range, September 2003‐April 2014), ventilation‐perfusion (VQ) 
scan (date range, January 2000‐April 2014), or D‐dimer testing (date 
range, January 2007‐April 2014). All patients with D‐dimer testing 
were included to capture a cohort of children in whom PE was even 
considered. Patients who had a D‐dimer obtained were identified 
by text search of ED records, and children undergoing CTPA or VQ 
scans were identified through radiology databases. Visits with a D‐
dimer test sent from the ED were reviewed manually (KEH) to en‐
sure that testing was performed specifically for PE. The study also 
excluded patients who were receiving anticoagulation treatment for 
PE. Missing data for specific variables were assumed to be absent. 
REDcap was used for data collection.
Kline et al included 541 patients in Indiana of age 5 to 17 years 
who underwent testing for PE with either a D‐dimer, CTPA, scintilla‐
tion lung scan, or formal pulmonary angiography between 2004 and 
2014 in the Indiana University Health hospital system.5 A pediatric 
tertiary care center (Riley Hospital) and 8 community hospitals are 
part of this system. Patients were identified by query of 2 databases 
for D‐dimer and pulmonary vascular imaging orders. Patients could 
be located in an ED, observation unit, hospital ward, or intensive care 
unit. To be included a patient had to either undergo a pulmonary vas‐
cular imaging study (CTPA, VQ lung scanning, or formal pulmonary 
angiography), or have a D‐dimer for suspected PE. Specific training 
was provided for data abstractors to determine if care providers or‐
dered D‐dimer for suspected PE. Suspicion for PE was determined 
if written words indicated that PE or a synonym, such as thrombo‐
embolism, was pertinently included in the medical record. Patients 
were excluded if D‐dimer was performed for another process, such 
as cancer surveillance or suspected disseminated intravascular co‐
agulation, or undetermined reason. Clinical data had to be docu‐
mented within 48 hours of the time of PE diagnosis to be included. 
The majority of the clinical data were obtained at the ED visit (with 
the triage vitals). Some data were obtained from an inpatient unit 
when there was not an ED visit documented. When variables were 
not mentioned in the chart, these were coded as absent. Data were 
then transferred to a REDCap electronic form.
For both studies, there was no way of determining the clinicians’ 
gestalt pretest probability when collecting PERC predictors.
2.1 | Criterion standard for PE
Hennelly et al4 determined PE status based on positive radiologic 
testing within 1 week of an ED visit, and required treatment with 
anticoagulation to confirm the presence of PE. Positive radiologic 
testing consisted of either (1) an intraluminal filling defect noted on 
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CTPA that was interpreted as PE by the final staff radiologist report 
or (2) a moderate‐ to high‐probability VQ scan. Patients with nega‐
tive or equivocal imaging studies not receiving treatment, as well as 
those with only a positive D‐dimer but no imaging, were considered 
not to have a PE. To ensure that patients were not characterized 
falsely as not having a PE, patients were longitudinally tracked at the 
study institution through the end of the study period to ensure that 
they did not undergo imaging for concern for PE.
Kline et al determined PE status by using imaging data and available 
outcome records. The definition of PE positive required a filling defect 
on CTPA interpreted as positive for PE or a ventilation‐perfusion scin‐
tillation lung scan interpreted as high probability. Patients with PE or 
DVT diagnosed within 30 days after the D‐dimer were considered to 
be PE positive. The exclusion of PE required negative imaging or a no 
PE diagnosis within 30 days, using a statewide database that tracks 
95% of hospitals in Indiana. Patients with a negative D‐dimer and no PE 
or DVT within 30 days were considered PE negative.
Both studies required positive imaging (by CTPA scan or VQ scan) 
to confirm a diagnosis of PE. A negative D‐dimer with no subsequent 
diagnosis of PE was considered to be negative for PE as described. 
Both studies included all patients who had D‐dimers sent out of con‐
cern for PE to best compare clinical factors among PE‐negative and 
‐positive patients.
2.2 | Analysis
We used the data dictionary from each database to ensure common‐
ality of terms, which identified 42 unique predictor variables that 
were coded in both databases. These were joined into single columns 
of predictor variables with unique patients in each row. To determine 
significant variables, we performed univariate, then multivariable 
analyses to develop prediction or prognostic rules.20,21 Prior to miss‐
ing data analysis and replacement, all 42 candidate variables were 
subjected to univariate screening by unpaired t‐tests for parametric 
data (eg, heart rate) or chi‐square statistic for bivariate data (eg, sex). 
Variables with P < 0.1 were retained, and missing data were replaced. 
Missing data were analyzed for monotonicity and replaced using the 
automatic function in the multiple imputations technique in SPSS 
(IBM, Armonk, NY, USA). We used the pooled data from 5 iterations 
to generate a new data set of candidate variables with no missing 
data for the remaining analysis. The remaining parametric data were 
further tested for discriminative significance using receiver operat‐
ing characteristic (ROC) analysis, then retaining variables with an 
area under the curve with lower limit 95% confidence interval > 0.5. 
Cutoff values for continuous variables were determined as the value 
corresponding to the peak likelihood ratio positive/likelihood nega‐
tive on the ROC curve. The remaining variables were then selected 
for significance using forward stepwise multivariable logistic regres‐
sion analysis with the dependent variable representing PE or no PE 
using the criterion standards above. Regression analyses were per‐
formed using SPSS Statistics, version 25 (IBM).
We then performed a sensitivity analysis to test if the variables 
retained by multivariable regression had different discriminative 
characteristics for PE based on age. This potential effect was 
demonstrated by producing frequency plots of continuous vari‐
ables (eg, heart rate), stratified by patient age ≤ 14 years, com‐
pared with age > 14 years, and performing a 1‐way analysis of 
variance (ANOVA) with Tukey’s post hoc to provide P values com‐
paring PE positive vs PE negative. For dichotomous variables (eg, 
prior history of VTE), we plotted the frequency of each variable, 
stratified by age ≤ 14 or > 14 years, and obtained a P value com‐
paring PE positive vs. PE negative from the exact binomial method 
(StatsDirect version 3.1.20, Cheshire, England). Figures were pro‐
duced in Prism version 7.00 for Windows (GraphPad Software, La 
Jolla, CA, USA).
3  | RESULTS
The combined database included 1103 children who underwent 
testing for PE in the emergency care setting. A total of 506 (45.9%) 
patients underwent CTPA or VQ scan imaging. Table 1 shows 
our patient demographics and differentiates patients who were 
positive (n = 93, 8.4%) or negative for PE. The median ages for 
TA B L E  1   Characteristics of pediatric patients evaluated for PE
Patient demographics
Characteristics
PE positive 
(n = 93)
PE negative 
(n = 1010)
n (%) n (%)
Demographics
Age (y), median [IQR] 15.2 [13.9‐20.0] 16.9 [15.0‐20.8]
Female sex 46 (49.5) 502 (49.7)
Comorbidities
Central venous catheter 9 (9.7) 24 (2.4)
Previous venous 
thromboembolism
28 (30.1) 39 (3.9)
Malignancy 12 (12.9) 41 (4.1)
Congenital heart disease 5 (5.4) 45 (4.5)
Renal disease 1 (1.1) 8 (0.8)
Recent immobility or surgery 25 (26.9) 82 (8.1)
Recent injury 6 (6.5) 30 (3.0)
Exogenous estrogen use 17 (18.3) 153 (15.1)
Symptoms/Exam findings
Syncope 1 (1.1) 51 (5.0%)
Chest pain 35 (38%) 553 (54.7%)
Cough 14 (15.1) 204 (20.2)
Shortness of breath 55 (59.1) 583 (57.7)
Fever 16 (17.2) 116 (11.5)
Hemoptysis 3 (3.2) 18 (1.8)
Calf swelling 15 (16.1) 26 (2.6)
O2 saturation < 95% 18 (19.4) 49 (4.9)
Abbreviations: IQR, interquartile range; PE, pulmonary embolism.
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PE‐positive and ‐negative patients were 15.2 and 16.9 years, re‐
spectively. Thirty percent of patients with PE had a prior DVT or 
PE, 26.9% had recent immobilization or surgery/trauma, and 12.9% 
had an active malignancy. Additionally, 51.6% of patients with PE 
had tachycardia for age based on the pediatric American Heart 
Association guidelines,22 and 16.1% had leg swelling. We were un‐
able to describe chest pain adequately (eg, substernal, pleuritic, 
or chest wall) based on the retrospective design, and therefore 
we did not analyze this variable as a predictor. Table S1 shows the 
screening P value results of univariate analysis on the 42 inde‐
pendent variables. The primary finding was that 17 variables had 
P < 0.1. Unless otherwise noted, variables were positively associ‐
ated with PE positive based on an increasing value or presence of 
the following variables: (1) age, (2) heart rate, (3) respiratory rate, 
(4) diastolic blood pressure (low diastolic blood pressure being a 
positive predictor), (5) pulse oximetry (low pulse oximetry being 
a positive predictor), (6) body mass, (7) hemoglobin concentration 
(low hemoglobin being a positive predictor), (8) white blood cell 
count, (9) sodium concentration (low sodium being a positive pre‐
dictor), (10) bicarbonate concentration, (11) prior VTE, (12) recent 
surgery or trauma requiring hospitalization, (13) indwelling cen‐
tral line, (14) active cancer, (15) asthma (presence of asthma being 
a negative predictor), (16) syncope (presence of syncope being a 
negative predictor), and (17) unilateral leg swelling. Notably, es‐
trogen use (including oral contraceptives) and hemoptysis did not 
yield P values < 0.1 sufficient for selection. The results of multi‐
ple imputations indicated the only missing data were 11 continu‐
ous variables, as shown in Table S2. The means of imputed values 
pooled from 5 iterations were compared with the preimputation 
means using an unpaired t‐test and were significant (P < 0.05) 
for all variables except bicarbonate, diastolic blood pressure, and 
body mass. The frequency of missing variables is shown in Table 
S2. Analysis by ROC then rejected these 3 plus 1 more variable 
(age, diastolic blood pressure, body mass, and serum bicarbonate) 
from entry into the multivariable stage. The ROC curve analysis 
also selected cutoff values of 24 breaths/min for respiratory rate, 
95% for pulse oximetry, 11.0 g/dL for hemoglobin, and 135 mEq/L 
for sodium. We did not use age‐adjusted respiratory rates but 
rather determined the ROC curve analysis cutoff value. For heart 
rate, we used data from the ROC as well as cutoffs for normal 
published in guidelines to establish the cutoffs of > 120 beats/min 
for age < 12 years and > 100 beats/min for age > 11 years (“age‐
adjusted tachycardia”).22
The remaining 13 variables were then subjected to stepwise 
forward multivariable logistic regression, which excluded 4 more 
variables (sodium < 135 mEq/L, syncope, asthma, and indwelling 
catheter). For the remaining 9 variables shown in Table 2, a main 
effects logistic regression yielded Hosmer‐Lemeshow P = 0.30, 
McFadden’s pseudo R2 = 0.247, and Pearson’s chi‐square goodness 
of fit P = 0.32. Table 2 presents the coefficients and odds ratios from 
logistic regression for the 9 variables retained as significantly predic‐
tive. Of note, unilateral limb swelling had an odds ratio of 7.4 (95% 
confidence interval [CI], 3.4‐16.4), and prior VTE had an odds ratio 
of 11.8 (95% CI, 6.3‐21.9).
3.1 | Sensitivity analyses
Figure 1 shows the effect of stratifying the continuous variables 
in Table 2 based on age below or above 14 years. The P values 
from the ANOVA and Tukey’s post hoc test on means demon‐
strated P > 0.05 for both age strata for respiratory rate and white 
blood count, and P > 0.05 in the age > 14 subgroup for SpO2 
and age. The most robust predictors (P < 0.05 in both age strata) 
were heart rate and hemoglobin. Similarly, Figure 2 plots the 
frequency analysis for the 4 categorical variables shows loss of 
discrimination in age ≤ 14 for recent surgery/trauma and cancer, 
while prior VTE and unilateral limb swelling had P < 0.05 in both 
age strata.
 Odds ratio
95% confidence interval for 
odds ratio
Lower bound Upper bound
Intercept … … …
Age‐adjusted tachycardia*  1.7 1.0 2.9
Hemoglobin < 11.0 g/dL 2.3 1.4 4.0
Respiratory rate > 23.5 1.8 1.1 3.0
SpO2 < 94.5% 1.9 1.0 3.5
White blood cell count > 11.0 × 103 cells/μL 2.1 1.3 3.5
Unilateral limb swelling 7.4 3.4 16.4
Active cancer 2.6 1.2 5.6
Prior venous thromboembolism 11.8 6.3 21.9
Trauma or surgery requiring hospitalization 
in past 4 weeks
2.1 1.1 3.7
Abbreviation: PE, pulmonary embolism.
*> 120 beats/min for age < 12 years and > 100 beats/min for age > 11 years. 
TA B L E  2   Factors associated with PE 
diagnosis among children evaluated for 
PE from forward stepwise multivariable 
regression
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F I G U R E  1   Frequency (dot‐plots) of 
continuous variables tested by logistic 
regression for each patient in the study, 
stratified on the x‐axis by age ≤ 14 years 
(leftward 2 plots) or > 14 years (rightward 
2 plots) and by pulmonary embolism 
(PE+) diagnosis (blue symbols) vs. no PE 
diagnosis (PE–, gray symbols). The P values 
were calculated from the Tukey’s post hoc 
test following 1‐way analysis of variance. 
SpO2, Pulse oximetry (%)
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4  | DISCUSSION
This work provides novel information from what we believe to be 
the largest multihospital database of consecutive pediatric patients 
evaluated for PE in the ED. From 42 candidate variables, the process 
of sequential univariate and then multivariable logistic regression re‐
vealed that age‐adjusted tachycardia (>119 beats/min for age < 12 
and > 99 beats/min for age > 11), tachypnea (respiratory rate > 23.5), 
hypoxia (pulse oximetry < 94.5%), unilateral limb swelling, trauma 
or surgery requiring hospitalization in the previous 4 weeks, prior 
thromboembolism, active cancer, anemia (hemoglobin concentra‐
tion < 11 g/dL), and leukocytosis (white blood count > 11.0 × 103 
cells/µL) were independently associated with a diagnosis of PE. The 
sensitivity analysis, including the data in Figures 1 and 2, stratifying 
age below or above 14 years was performed because the risk factors 
for and physical manifestations of VTE may vary with age. Findings 
here suggest factors associated with a diagnosis of PE among chil‐
dren suspected of PE might be different by age. Specifically, heart 
rate, hemoglobin concentration, prior VTE, and unilateral limb swell‐
ing were robust in those above or below age 14, while respiratory 
rate and white blood cell count were no longer statistically significant 
when analysis was stratified by age. These data provide a hypothesis 
that these variables may remain significantly predictive of PE diag‐
nosis in a prospective study. With further validation, ≥1 of these 4 
novel criteria may enhance PERC rule diagnostic accuracy in children.
Strengths of this work include the multicenter representation 
and that this sample represents a consecutive sample and not a 
case‐control sample. We used rigorous methods to handle missing 
data and to select variables, including multivariable analysis that 
demonstrates evidence of good model fitness based on the Hosmer‐
Lemeshow P value.
Our study has several limitations. First, both data sets were 
collected retrospectively and therefore relied on a criterion stan‐
dard of follow‐up based on findings in electronic health records. 
However, both populations would have likely returned to our large 
tertiary care centers if they had a subsequent PE, and thus would 
have been discovered in our data sets. The sensitivity analysis found 
that respiratory rate and white blood cell count were significant only 
in the entire patient sample, but this significance was lost with age 
stratification. This suggests that the inherent vulnerability to the 
univariable‐multivariable approach to finding clinically relevant sub‐
group interactions that affect predictive strength of independent 
variables. Next, we combined data that did not have the exact same 
abstraction methods. For example, we assumed that variables that 
were not explicitly mentioned in the medical record (eg, syncope) 
were absent. We did extract 42 variables using the same definitions 
in our datasets and, therefore, could confidently perform the uni‐
variable‐multivariable selection method on these. Additionally, our 
studies did not use the same age criteria. Kline et al5 included pa‐
tients aged 5 to 18 years, and Hennelly et al4 included patients from 
birth to age 21. This is unlikely significant given that only 6 patients 
with PE were under the age of 5 years. The presentation of PE is 
variable in the different age extremes, and ideally prospective work 
will better clarify these differences. Another limitation is the lack of 
definitive imaging for all patients. This was likely due to low clini‐
cian suspicion and negative D‐dimer testing, coupled with a desire 
to limit pediatric radiation exposure. However, we felt that no return 
visits with a diagnosis of PE made it unlikely that there were missed 
F I G U R E  2   Frequency bar plots for 
dichotomous variables tested by logistic 
regression, stratified on the x‐axis 
by age ≤ 14 years (leftward 2 plots) 
or > 14 years (rightward 2 plots), and by 
pulmonary embolism (PE+) diagnosis (blue 
symbols) vs. no PE diagnosis (PE–, gray 
symbols). The P values were calculated 
from the exact binomial formula for 
differences in proportions. VTE, venous 
thromboembolism
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diagnoses in these patients. And finally, given the retrospective na‐
ture of our studies, we were unable to assess physicians’ gestalt pre‐
test probability for suspicion of PE.
In conclusion, a pooled database from 2 states confirmed 5 pre‐
viously recognized predictors of PE diagnosis in children suspected 
of PE (hypoxia, unilateral limb swelling, trauma or surgery requiring 
hospitalization in the previous 4 weeks, prior thromboembolism, and 
active cancer), and identified 4 novel factors (age‐adjusted tachy‐
cardia, tachypnea, anemia, and leukocytosis). A future prospective 
multicenter study stratifying by age is needed for children suspected 
of PE to better define those with a PE diagnosis.
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